Table 1 Patient, tumour and treatment characteristics
Patient characteristics | No. of patients (%) |
|---|---|
Total | 82 |
Sex (male/female) | 8 (9.8%) / 74 (90.2%) |
Median age | 63.5 ± 11.9 years (range: 40–96 years) |
Positive HIV serology | 1 (1.2%) |
TNM stage | |
T1 | 6 (7.3%) |
T2 | 34 (41.5%) |
T3 | 27 (32.9%) |
T4 | 15 (18.3%) |
N0 | 34 (41.5%) |
N1 | 20 (24.4%) |
N2 | 13 (15.9%) |
N3 | 15 (18.3%) |
Radiotherapy and chemotherapy | |
Exclusive radiotherapy | 22 (26.8%) |
Concurrent CRT | 60 (73.2%) |
Cisplatin-based | 50 |
Mitomycin-C-based | 6 |
Capecitabine | 4 |